AstraZeneca Aktie
171,20
EUR
+0,55
EUR
+0,32
%
204,52
USD
-0,24
USD
-0,12
%
Werbung
AstraZeneca Aktie Analyse
| 29.10.19 | AstraZeneca buy | Kepler Cheuvreux | |
| 29.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.10.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 28.10.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 25.10.19 | AstraZeneca buy | Deutsche Bank AG | |
| 25.10.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 24.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 24.10.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 24.10.19 | AstraZeneca Sell | UBS AG | |
| 22.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 17.10.19 | AstraZeneca Reduce | HSBC | |
| 15.10.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 14.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 08.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 01.10.19 | AstraZeneca Reduce | HSBC | |
| 01.10.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.09.19 | AstraZeneca buy | Deutsche Bank AG | |
| 30.09.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 20.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 16.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 13.09.19 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
| 13.09.19 | AstraZeneca overweight | Barclays Capital | |
| 10.09.19 | AstraZeneca Sell | UBS AG | |
| 09.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.09.19 | AstraZeneca buy | Deutsche Bank AG | |
| 06.09.19 | AstraZeneca overweight | Barclays Capital | |
| 05.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 02.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.08.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 29.08.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 28.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 21.08.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 21.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.08.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 16.08.19 | AstraZeneca overweight | Barclays Capital | |
| 14.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.08.19 | AstraZeneca overweight | Barclays Capital | |
| 09.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 07.08.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 05.08.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.07.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.07.19 | AstraZeneca buy | Deutsche Bank AG | |
| 26.07.19 | AstraZeneca overweight | Barclays Capital | |
| 26.07.19 | AstraZeneca buy | Deutsche Bank AG | |
| 26.07.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 25.07.19 | AstraZeneca Sell | UBS AG | |
| 25.07.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 10.07.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 08.07.19 | AstraZeneca buy | Deutsche Bank AG | |
Werbung
Werbung